These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 21112153)

  • 1. Comparison of two assays, a faecal egg count reduction test (FECRT) and a coproantigen reduction test (CRT), for the diagnosis of resistance to triclabendazole in Fasciola hepatica in sheep.
    Flanagan A; Edgar HW; Gordon A; Hanna RE; Brennan GP; Fairweather I
    Vet Parasitol; 2011 Mar; 176(2-3):170-6. PubMed ID: 21112153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Standardisation of a coproantigen reduction test (CRT) protocol for the diagnosis of resistance to triclabendazole in Fasciola hepatica.
    Flanagan AM; Edgar HW; Forster F; Gordon A; Hanna RE; McCoy M; Brennan GP; Fairweather I
    Vet Parasitol; 2011 Feb; 176(1):34-42. PubMed ID: 21093156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fasciola hepatica: a comparative survey of adult fluke resistance to triclabendazole, nitroxynil and closantel on selected upland and lowland sheep farms in Northern Ireland using faecal egg counting, coproantigen ELISA testing and fluke histology.
    Hanna RE; McMahon C; Ellison S; Edgar HW; Kajugu PE; Gordon A; Irwin D; Barley JP; Malone FE; Brennan GP; Fairweather I
    Vet Parasitol; 2015 Jan; 207(1-2):34-43. PubMed ID: 25529143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An evaluation of the efficacy of compound alpha and triclabendazole against two isolates of Fasciola hepatica.
    McConville M; Brennan GP; Flanagan A; Edgar HW; Hanna RE; McCoy M; Gordon AW; Castillo R; Hernández-Campos A; Fairweather I
    Vet Parasitol; 2009 May; 162(1-2):75-88. PubMed ID: 19282108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. On farm evaluation of the coproantigen ELISA and coproantigen reduction test in Scottish sheep naturally infected with Fasciola hepatica.
    Gordon DK; Zadoks RN; Stevenson H; Sargison ND; Skuce PJ
    Vet Parasitol; 2012 Jul; 187(3-4):436-44. PubMed ID: 22421492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of an egg hatch assay for the diagnosis of triclabendazole resistance in Fasciola hepatica: proof of concept.
    Fairweather I; McShane DD; Shaw L; Ellison SE; O'Hagan NT; York EA; Trudgett A; Brennan GP
    Vet Parasitol; 2012 Feb; 183(3-4):249-59. PubMed ID: 21821359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative kinetics of serological and coproantigen ELISA and faecal egg count in cattle experimentally infected with Fasciola hepatica and following treatment with triclabendazole.
    Brockwell YM; Spithill TW; Anderson GR; Grillo V; Sangster NC
    Vet Parasitol; 2013 Sep; 196(3-4):417-26. PubMed ID: 23643623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Composite faecal egg count reduction test to detect resistance to triclabendazole in Fasciola hepatica.
    Daniel R; van Dijk J; Jenkins T; Akca A; Mearns R; Williams DJ
    Vet Rec; 2012 Aug; 171(6):153, 1-5. PubMed ID: 22791519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The field evaluation of albendazole and triclabendazole efficacy against Fasciola hepatica by coproantigen ELISA in naturally infected sheep.
    Novobilský A; Averpil HB; Höglund J
    Vet Parasitol; 2012 Nov; 190(1-2):272-6. PubMed ID: 22818198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resistance of Fasciola hepatica against Triclabendazole in cattle in Cajamarca (Peru): a clinical trial and an in vivo efficacy test in sheep.
    Ortiz P; Scarcella S; Cerna C; Rosales C; Cabrera M; Guzmán M; Lamenza P; Solana H
    Vet Parasitol; 2013 Jul; 195(1-2):118-21. PubMed ID: 23352107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The diagnosis of fasciolosis in feces of sheep by means of a PCR and its application in the detection of anthelmintic resistance in sheep flocks naturally infected.
    Robles-Pérez D; Martínez-Pérez JM; Rojo-Vázquez FA; Martínez-Valladares M
    Vet Parasitol; 2013 Oct; 197(1-2):277-82. PubMed ID: 23743420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fasciola hepatica: histological changes in the reproductive structures of triclabendazole (TCBZ)-sensitive and TCBZ-resistant flukes after treatment in vivo with TCBZ and the related benzimidazole derivative, Compound Alpha.
    Hanna RE; Edgar HW; McConnell S; Toner E; McConville M; Brennan GP; Devine C; Flanagan A; Halferty L; Meaney M; Shaw L; Moffett D; McCoy M; Fairweather I
    Vet Parasitol; 2010 Mar; 168(3-4):240-54. PubMed ID: 20053501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of flukicide efficacy against Fasciola hepatica in sheep in Sweden in the absence of a standardised test.
    Novobilský A; Amaya Solis N; Skarin M; Höglund J
    Int J Parasitol Drugs Drug Resist; 2016 Dec; 6(3):141-147. PubMed ID: 27380550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MM3-ELISA evaluation of coproantigen release and serum antibody production in sheep experimentally infected with Fasciola hepatica and F. gigantica.
    Valero MA; Ubeira FM; Khoubbane M; Artigas P; Muiño L; Mezo M; Pérez-Crespo I; Periago MV; Mas-Coma S
    Vet Parasitol; 2009 Jan; 159(1):77-81. PubMed ID: 19019548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An ultrasensitive capture ELISA for detection of Fasciola hepatica coproantigens in sheep and cattle using a new monoclonal antibody (MM3).
    Mezo M; González-Warleta M; Carro C; Ubeira FM
    J Parasitol; 2004 Aug; 90(4):845-52. PubMed ID: 15357080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative assessment of albendazole and triclabendazole ovicidal activity on Fasciola hepatica eggs.
    Alvarez L; Moreno G; Moreno L; Ceballos L; Shaw L; Fairweather I; Lanusse C
    Vet Parasitol; 2009 Oct; 164(2-4):211-6. PubMed ID: 19560276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Triclabendazole resistance in Fasciola hepatica: First report in sheep from the Santa Cruz province, Argentinian Patagonia.
    Larroza M; Aguilar M; Soler P; Mora J; Roa M; Cabrera R; Martinez Stanziola JP; Ceballos L; Alvarez LI
    Vet Parasitol Reg Stud Reports; 2023 Oct; 45():100927. PubMed ID: 37783530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fasciola hepatica: comparative effects of host resistance and parasite intra-specific interactions on size and reproductive histology in flukes from rats infected with isolates differing in triclabendazole sensitivity.
    Hanna RE; Gordon AW; Moffett D; Edgar HW; Oliver LF; McConnell S; Shaw L; Brennan GP; Fairweather I
    Vet Parasitol; 2011 Jun; 178(3-4):251-63. PubMed ID: 21333449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clonal amplification of Fasciola hepatica in Galba truncatula: within and between isolate variation of triclabendazole-susceptible and -resistant clones.
    Hodgkinson JE; Cwiklinski K; Beesley N; Hartley C; Allen K; Williams DJL
    Parasit Vectors; 2018 Jun; 11(1):363. PubMed ID: 29941045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High prevalence of fasciolosis and evaluation of drug efficacy against Fasciola hepatica in dairy cattle in the Maffra and Bairnsdale districts of Gippsland, Victoria, Australia.
    Elliott TP; Kelley JM; Rawlin G; Spithill TW
    Vet Parasitol; 2015 Apr; 209(1-2):117-24. PubMed ID: 25771931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.